ArticleCancer medicine2023

Impact of programmed death-ligand 1 (PD-L1) positivity on clinical and molecular features of patients with metastatic gastric cancer.

Minkyue Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.